These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9418155)

  • 1. Issues on antiretroviral post exposure combination prophylaxis.
    Puro V; Ippolito G
    J Biol Regul Homeost Agents; 1997; 11(1-2):11-9. PubMed ID: 9418155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-exposure HIV prevention within and outside the hospital].
    Jost J
    Ther Umsch; 1998 May; 55(5):289-94. PubMed ID: 9643126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated postexposure guidelines stress need for expert advice.
    AIDS Alert; 1998 Jul; 13(7):73-5. PubMed ID: 11365585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEPping up your HIV defenses.
    Torres G
    GMHC Treat Issues; 1998 May; 12(5):8-9. PubMed ID: 11365480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV exposure through contact with body fluids.
    Prescrire Int; 2012 Apr; 21(126):100-1, 103-5. PubMed ID: 22515138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.
    Pinkerton SD; Holtgrave DR; Bloom FR
    AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention.
    AIDS Alert; 1997 Sep; 12(9):97-100. PubMed ID: 11364588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of HIV infection.
    Omrani AS; Freedman A
    Br Med Bull; 2005; 73-74():93-105. PubMed ID: 16207801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe.
    Almeda J; Casabona J; Simon B; Gerard M; Rey D; Puro V; Thomas T;
    Euro Surveill; 2004 Jun; 9(6):35-40. PubMed ID: 15223890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-HIV chemoprophylaxis for blood-exposure accidents].
    Bouvet E; Casalino E
    Ann Med Interne (Paris); 2000 Jun; 151(4):283-90. PubMed ID: 10922956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New guidelines issued for occupational exposures.
    AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV prone occupational exposures: epidemiology and factors associated with initiation of post-exposure prophylaxis.
    Zenner D; Tomkins S; Charlett A; Wellings K; Ncube F
    J Epidemiol Community Health; 2009 May; 63(5):373-8. PubMed ID: 19188197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Registry finds 3 drugs most favored PEP regimen.
    AIDS Alert; 1998 Jul; 13(7):75-6. PubMed ID: 11365586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term adverse effects from and discontinuation of antiretroviral post-exposure prophylaxis.
    Puro V; De Carli G; Orchi N; Palvarini L; Chiodera A; Fantoni M; Del Borgo C; Iemoli E; Niero F; Monti M; Micheloni G; Caggese L; Lodesani C; Raineri G; Massari M; Drenaggi D; Ippolito G;
    J Biol Regul Homeost Agents; 2001; 15(3):238-42. PubMed ID: 11693431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.